SGI-DNA, INC. – Trademark Portfolio
Entity Type: 03
SGI-DNA, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 7 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include BIOXP and GIBSON ASSEMBLY. The owner is based in SAN DIEGO, CA.
9535 WAPLES STREET, SUITE 100
SAN DIEGO, CA 92121
Showing of trademarks Trademarks
Trademark Classifications
SGI-DNA, INC.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SGI-DNA, INC. have?
SGI-DNA, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does SGI-DNA, INC. file in?
SGI-DNA, INC. files trademarks across 7 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are SGI-DNA, INC.'s most well-known trademarks?
SGI-DNA, INC.'s registered trademark portfolio includes well-known marks such as BIOXP and GIBSON ASSEMBLY. These are among 3 currently registered trademarks in the portfolio.
What is SGI-DNA, INC.'s trademark registration success rate?
SGI-DNA, INC. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.